GPT and Jaundice: The results showed that MenSCs could significantly reduce the levels of AST (169.4 vs. 108.0 U/L, p < 0.001), ALT (279.0 vs. 228.9 U/L, p < 0.01), ALP (45.6 vs. 10.6 U/L, p < 0.0001), DBIL (108.3 vs. 14.0 μmol/L, p < 0.0001) and TBIL (179.2 vs. 43.3 μmol/L, p < 0.0001), indicating that MenSC transplantation could restore DDC-induced mouse liver damage and liver damage-induced jaundice (Fig. 2E).